Research feed

Latest Diabetes Research

Recently added diabetes research, organized by intervention and outcome.

Sorted by when Dediabetes added each study.

Last updated: Sep 12, 20261,338 studies indexed

September 2026

Added to Dediabetes Sep 12, 2026RCTs

Liraglutide may reduce BMI in youth with type 2 diabetes

This study evaluated the efficacy of liraglutide compared to placebo for weight loss in children and adolescents with type 2 diabetes, revealing some reduction in BMI metrics.

Interventions
Liraglutide
Outcomes
Body Mass Index (BMI) change
Added to Dediabetes Sep 12, 2026RCTs

Liraglutide improves beta-cell function in type 2 diabetes

The study investigated the effects of liraglutide on beta-cell function in individuals with well-controlled type 2 diabetes, finding a significant improvement in the disposition index.

Interventions
Liraglutide
Outcomes
Disposition IndexGlucagonInsulin clearance+2 more
Added to Dediabetes Sep 12, 2026RCTs

Exenatide improves glucose control in type 2 diabetes

Once-weekly exenatide significantly improved glycaemic control in adults with type 2 diabetes compared to placebo.

Interventions
Exenatide
Outcomes
2-hour plasma glucoseFasting Plasma Glucose (FPG)Gastrointestinal disorders incidence+7 more
Added to Dediabetes Sep 12, 2026RCTs

Exenatide improves weight loss compared to glargine in type 2 diabetes

This study compared the effects of exenatide and insulin glargine on body composition in overweight and obese patients with type 2 diabetes. Exenatide significantly reduced body weight and fat mass, while glargine increased these measures.

Interventions
ExenatideGlargine U100
Outcomes
BMIBeta-cell functionBody fat mass+2 more
Added to Dediabetes Sep 12, 2026RCTs

Liraglutide reduces sST2 levels in diabetes patients

Liraglutide treatment significantly reduced sST2 levels in obese patients with prediabetes or early T2DM, while lifestyle counseling had no significant effect.

Interventions
Behavioral counselingLiraglutide
Outcomes
Gal-3hs-Troponin IsST2
Added to Dediabetes Sep 12, 2026RCTs

GLP-1 and DPP-4 Inhibitors Show No Effect on Gallbladder Volume

This study investigated the effects of GLP-1 receptor agonists and DPP-4 inhibitors on gallbladder volume and bile acid profiles in type 2 diabetes patients, finding significant changes in bile acid levels with liraglutide and sitagliptin.

Interventions
LiraglutideSitagliptin
Outcomes
Change in Serum IL-1β LevelsFaecal chenodeoxycholic acidFaecal cholic acid+4 more
Added to Dediabetes Sep 12, 2026RCTs

Incretins show little effect on insulin clearance in type 2 diabetes

This randomized controlled trial investigated the effects of incretin-based therapies on insulin clearance in type 2 diabetes. It found significant differences in insulin clearance between treatments.

Interventions
GIPGLP-1 receptor agonistsGLP-1/GIP Combination+3 more
Outcomes
Blood glucoseC-peptideInsulin clearance+4 more

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.